Kevin Siska

Kevin Siska serves as the Sr. Regional Sales Director for NF1 PN at Alexion Pharmaceuticals, Inc. since August 2020, previously holding the position of Regional Sales Director for NYC. Prior to this role, Kevin was Regional Business Director at Portola Pharmaceuticals and La Jolla Pharmaceutical Company, where responsibilities included the commercialization of innovative therapies for severe diseases. Kevin's extensive experience at The Medicines Company included leading specialized hospital sales teams and achieving notable President's Club Awards for sales growth. Earlier career roles include Cardiovascular Account Specialist at CV Therapeutics and Specialty Representative at First Horizon Pharmaceutical. Kevin holds an M.B.A. from The College of Saint Rose and a Bachelor's degree in Management from Rensselaer Polytechnic Institute.